121 related articles for article (PubMed ID: 7721328)
1. Restoration of murine cytomegalovirus (MCMV) induced myelosuppression by AS101.
Sredni B; Rosenthal-Galili Z; Michlin H; Sobelman D; Seger Y; Blagerman S; Kalechman Y; Rager-Zisman B
Immunol Lett; 1994 Dec; 43(3):159-65. PubMed ID: 7721328
[TBL] [Abstract][Full Text] [Related]
2. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101).
Kalechman Y; Sotnik-Barkai I; Albeck M; Sredni B
Cancer Res; 1993 Apr; 53(8):1838-44. PubMed ID: 8467503
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate.
Kalechman Y; Zuloff A; Albeck M; Strassmann G; Sredni B
Blood; 1995 Mar; 85(6):1555-61. PubMed ID: 7888674
[TBL] [Abstract][Full Text] [Related]
4. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
Kalechman Y; Rushkin G; Nerubay J; Albeck M; Sredni B
Exp Hematol; 1995 Dec; 23(13):1358-66. PubMed ID: 7498364
[TBL] [Abstract][Full Text] [Related]
5. Radioprotective effects of the immunomodulator AS101.
Kalechman Y; Albeck M; Oron M; Sobelman D; Gurwith M; Seghal SN; Sredni B
J Immunol; 1990 Sep; 145(5):1512-7. PubMed ID: 2384668
[TBL] [Abstract][Full Text] [Related]
6. The protective role of ammonium trichloro(dioxoethylene-O,O')tellurate in combination with several cytotoxic drugs acting by different mechanisms of action.
Kalechman Y; Shani A; Sotnik-Barkai I; Albeck M; Sredni B
Cancer Res; 1993 Dec; 53(24):5962-9. PubMed ID: 8261410
[TBL] [Abstract][Full Text] [Related]
7. Protective and restorative role of AS101 in combination with chemotherapy.
Kalechman Y; Albeck M; Oron M; Sobelman D; Gurwith M; Horwith G; Kirsch T; Maida B; Sehgal SN; Sredni B
Cancer Res; 1991 Mar; 51(5):1499-503. PubMed ID: 1997189
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of radioprotection conferred by the immunomodulator AS101.
Kalechman Y; Gafter U; Barkai IS; Albeck M; Sredni B
Exp Hematol; 1993 Jan; 21(1):150-5. PubMed ID: 8417951
[TBL] [Abstract][Full Text] [Related]
9. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
10. Analysis of hematopoietic stem and progenitor cell populations in cytomegalovirus-infected mice.
Gibbons AE; Price P; Shellam GR
Blood; 1995 Jul; 86(2):473-81. PubMed ID: 7541663
[TBL] [Abstract][Full Text] [Related]
11. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.
Lagneaux L; Delforge A; Snoeck R; Stryckmans P; Bron D
Exp Hematol; 1994 Jan; 22(1):26-30. PubMed ID: 7506672
[TBL] [Abstract][Full Text] [Related]
12. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
[TBL] [Abstract][Full Text] [Related]
13. In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin.
Kalechman Y; Albeck M; Sredni B
Cell Immunol; 1992 Aug; 143(1):143-53. PubMed ID: 1623562
[TBL] [Abstract][Full Text] [Related]
14. Use and mechanism of action of AS101 in protecting bone marrow colony forming units-granulocyte-macrophage following purging with ASTA-Z 7557.
Kalechman Y; Barkai IS; Albeck M; Horwith G; Sehagl SN; Sredni B
Cancer Res; 1991 Oct; 51(20):5614-20. PubMed ID: 1913679
[TBL] [Abstract][Full Text] [Related]
15. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
[TBL] [Abstract][Full Text] [Related]
16. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
[TBL] [Abstract][Full Text] [Related]
17. Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties.
Kalechman Y; Shani A; Albeck M; Sredni B
Immunopharmacology; 1995 Mar; 29(2):149-58. PubMed ID: 7539780
[TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
19. In vivo disturbance of hematopoiesis in mice persistently infected with murine cytomegalovirus: impairment of stromal cell function.
Mori T; Nakamura M; Shimizu K; Ikeda Y; Ando K
Virology; 1999 Jan; 253(2):145-54. PubMed ID: 9918873
[TBL] [Abstract][Full Text] [Related]
20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
